Chen Bihua 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:05 pm Purchase |
2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Chen Bihua | 8,494,151 14.170% |
1,602,051 (+23.24%) |
Filing |
| 2023-03-31 4:23 pm Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Chen Bihua | 6,892,100 17.600% |
6,892,100 (New Position) |
Filing |